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Objective: Approximately 5% of women suffer from recurrent vulvovaginal candidiasis
(RVVC). It has been hypothesized that genetic factors play an important role in the
susceptibility to RVVC. The aim of this study was to assess the effect of genetic variants
of genes encoding for pattern recognition receptors (PRRs) on susceptibility to RVVC.
Study design: For the study, 119 RVVC patients and 263 healthy controls were recruited.
Prevalence of polymorphisms in ﬁve PRRs involved in recognition of Candida were
investigated in patients and controls. In silico and functional studies were performed to
assess their functional effects.
Results: Single nucleotide polymorphisms (SNPs) inTLR1,TLR4, CLEC7A, and CARD9 did
not affect the susceptibility to RVVC. In contrast, a non-synonymous polymorphism inTLR2
(rs5743704, Pro631His) increased the susceptibility to RVVC almost 3-fold. Furthermore,
the TLR2 rs5743704 SNP had deleterious effects on protein function as assessed by in
silico analysis, and in vitro functional assays suggested that it reduces production of IL-17
and IFNγ upon stimulation of peripheral blood mononuclear cells with Candida albicans.
No effects were observed on serum mannose-binding lectin concentrations.
Condensation: This study demonstrates the association of susceptibility to RVVC with
genetic variation inTLR2, most likely caused by decreased induction of mucosal antifungal
host defense.
Conclusion: Genetic variation inTLR2 may signiﬁcantly enhance susceptibility to RVVC by
modulating host defense mechanisms against Candida. Additional studies are warranted
to assess systematically the role of host genetic variation for susceptibility to RVVC.
Keywords: RVVC, genetic variation, pattern recognition receptors, cytokines
INTRODUCTION
Candida microorganisms, especially Candida albicans, often col-
onize the genital tract in women, and under certain conditions
are responsible for mucosal inﬂammation (Hurley, 1977; Fleury,
1981; Odds, 1988; Fidel and Sobel, 1996; Giraldo et al., 2000; Sobel,
2007). Vulvovaginal candidiasis (VVC) is a frequent consequence
of Candida infection, accompanied by variable pruritus, soreness,
rash, and vaginal discharge, with patients experiencing a strong
discomfort. Most women have at least one event of VVC in their
lifetime, while up to 5–8% suffer from recurrent vulvovaginal
candidiasis (RVVC), deﬁned as at least three infections per year
(Hurley, 1977; Sobel, 2007).
Known risk factors of vulvovaginal candidiasis include diabetes,
pregnancy, and therapy with glucocorticosteroids, immunosup-
pressive drugs, and antibiotics (Milsom and Forssman, 1985;
Sobel, 1985; Kent, 1991). However, the vast majority of RVVC
patients are healthy women without any identiﬁable predis-
posing or episode precipitating factors (Morton, 1977; Sobel,
1985,1993; Kent, 1991; Mardh et al., 2002). Moreover, no dis-
tinct C. albicans strains, the species that causes more that 90%
of the VVC episodes, have been described in RVVC patients,
arguing against microbiological factors as the major determi-
nants of VVC or susceptibility to recurrent disease (Kent, 1991;
Sobel, 1993). Thus, it has been hypothesized that host genetic
factors may be a major component determining susceptibility to
RVVC.
The innate immune system provides the ﬁrst barrier against
vulvovaginal Candida infection. Pattern recognition receptors
(PRRs) on innate immune cells sense molecular moieties on the
surface of microorganisms, and thereafter induce an intracellular
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signal that stimulates production of effector molecules such as
cytokines or defensins. Two classes of PRRs have been reported to
be the main recognition receptors for C. albicans: Toll-like recep-
tors (TLRs) and C-type lectin receptors (CLRs; Netea et al., 2008).
TLR4 recognizes fungal cell wall mannans, while TLR2/TLR1
and TLR2/TLR6 heterodimers recognize Candida phospholipo-
mannan (Jouault et al., 2003). Additionally, TLR2 synergizes with
DECTIN-1, the receptor for β-glucan, for the induction of proin-
ﬂammatory cytokines (Brown et al., 2003; Gantner et al., 2003).
DECTIN-1 can also induce TLR-independent signals for the
production of IL-17, IL-6, and IL-10 through a Syk/CARD9-
dependent pathway (Gow et al., 2007). Single nucleotide poly-
morphisms (SNPs) in both TLRs and CLRs have been described
to be associated with an increased susceptibility to both sys-
temic (Plantinga et al., 2012) and oropharyngeal (Plantinga et al.,
2010) candidiasis, and we hypothesized that similar effects may be
exerted on the susceptibility to RVVC.
The aim of this study was to assess the impact of the
SNPs in the genes coding for DECTIN-1 (Tyr238X, rs16910526),
CARD9 (Ser12Asn, rs4077515), TLR1 (Arg80Thr, rs5743611),
TLR2 (Pro631His, rs5743704), and TLR4 (Asp299Gly, rs4986790;
Thr399Ile, rs4986791) on the susceptibility to RVVC.
MATERIALS AND METHODS
ETHICS STATEMENT
The inclusion of patients and controls in this study was approved
by the Institutional Review Boards of the Radboud University
Medical Centre, School of Medicine, Wayne State University and
Hôpital Necker. Enrollment took place between January 2010 and
December 2011. Patients gave written informed consent and the
study was in accordance to the declaration of Helsinki.
Enrolment of healthy controls for blood donations was
approved by the Institutional Review Board of the Radboud
University Medical Centre.
PATIENTS AND CONTROL SUBJECTS
The patient cohort consisting of 119 RVVC patients were recruited
at Wayne State University School of Medicine (Detroit, MI,
USA), Radboud University Nijmegen Medical Center (Nijmegen,
Netherlands) and Hôpital Necker (Paris, France). Patients were
enrolled during episodes of acute vaginitis or, if asymptomatic,
while receiving maintenance ﬂuconazole therapy. Inclusion cri-
teria for the study were: healthy women above 18 years of age,
diagnosed with at least three documented episodes of VVC in
a year, microbiologically validated and all caused by C. albi-
cans. Exclusion criteria were use of any immunosuppressive
therapy (including steroids), diabetes, pregnancy, and HIV infec-
tion. EDTA venous blood was collected after obtaining written
informed consent. Asymptomatic healthy controls without a his-
tory of vaginal Candida infections (N = 263) were recruited at
Radboud University Nijmegen Medical Center, Nijmegen,Nether-
lands and gave written informed consent. All patients and controls
were of Western-European genetic background.
GENOTYPING OF THE SINGLE NUCLEOTIDE POLYMORPHISMS
Genomic DNA was isolated from whole blood using the
Qiagen (Valencia, CA, USA) isolation kit and following the
standard protocol. The genotype for the CLEC7A (DECTIN-
1) Tyr328X (rs16910526) and CARD9 Ser12Asn (rs4077515)
polymorphisms in the patients was screened by the TaqMan
SNP assay C_33748481_10 and C_25956930_20, respectively,
(Applied Biosystems, Foster City, CA, USA). The genotype for
the TLR1 polymorphism Arg80Thr (rs5743611) was assessed
with the TaqMan SNP assay C_27855269_10. The genotype
of TLR2 Pro631His (rs5743704) was assessed by applying a
predesigned TaqMan SNP assay C_25607736_10. The genotyp-
ing for the TLR4 polymorphisms Asp299Gly (rs4986790) and
Thr399Ile (rs4986791) was performed with the TaqMan SNP assay
C_11722238_20 and C_11722237_20, respectively. The TaqMan
qPCR assays were performed on the 7300 ABI Real-Time poly-
merase chain reaction system (Applied Biosystems). Positive and
negative controls were included in the assays.
BIOINFORMATIC ANALYSIS FOR THE TLR2 POLYMORPHISM rs5743704
TheTLR2 protein informationwas obtained fromSwissprot acces-
sion code O60603, and OMIM accession code 603028, using the
MRS server1. We used the PROSITE server2 to retrieve informa-
tion about the TLR2 protein domains. No protein structure is
available for the complete TLR2 protein at the moment. However,
the cytoplasmic TIR domain is known and can be found as PDB-
ﬁle 1O77 (Tao et al., 2002). This structure in this ﬁle contains a
mutation on position 713 and misses one loop, but the remaining
residues are 100% identical to the sequence of TLR2.
The extracellular domain up to residue 509 is 100% identical
to the protein in PDB ﬁle 2Z7X (Jin et al., 2007). The Pro631His
polymorphism is located in the region linking the TIR domain
with the intracellular domain. We used the automatic modeling
script in the YASARA & WHAT IF Twinset (Krieger et al., 2002)
to extend the known structures and to model missing loops in
these structures. As a result, we produced models of the N- and of
the C-terminal domain, which are both accurate, because they are
based on the known structure of that protein. These structures are
extended with residues of the linking region. Additionally, we used
HOPE3, a next generation bioinformaticsweb server that performs
automatic mutant analysis (Venselaar et al., 2010). Besides this, an
analysis of the pathogenicity of the Pro631His polymorphism in
TLR2 was performed using conservation and structural informa-
tion. The Polyphen-2, SIFT, PANTHER, snps3D, and the SNAP
servers where employed for this analysis.
CYTOKINE STIMULATION ASSAYS
Peripheral blood mononuclear cells (PBMCs) were isolated from
73 healthy volunteers by Ficoll-Paque gradient. All healthy vol-
unteers gave written informed consent. 0.5 × 106 PBMCs/well
were plated in round bottom wells plates. Subsequently, incuba-
tion with C. albicans blastoconidia (1 × 106/mL, heat-killed at
100◦C for 1 h) was performed for 24 h, 48 h or 7 days. The incu-
bation time varied for each cytokine: 24 h for IL-1β and IL-6, 48 h
for IFNγ and IL-10, and 7 days for IL-17 (with the addition of
10% human serum). After the incubation time, cytokines were
1http://mrs.cmbi.ru.nl/mrs-web
2http://expasy.org/prosite
3http://www.cmbi.ru.nl/hope
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measured in the supernatants by ELISA (R&D Systems, MN, USA
or Sanquin Research, Amsterdam, Netherlands). Detection limits
were 40 pg/mL, except for the IFNγ ELISA (12 pg/mL). Mannose-
binding lectin (MBL) concentrations in serum were measured by
ELISA (Bioporto, Gentofte, Denmark).
STATISTICAL ANALYSIS
For the analysis of the polymorphisms in the PRRs, statistical
comparisons of frequencies weremade between RVVC versus con-
trol subjects. We used SPSS 16.0 software to perform Chi-square
tests and the 5% Conﬁdence Intervals Odds ratio to calculate
the risk. Furthermore, for the analysis of the effect of the TLR2
genotype on the in vitro cytokine production, a non-parametrical
Kruskal–Wallis analysis was performed, and for the circulatory
MBLmeasurementwe used theMann–WhitneyU-test. Both anal-
yses were done using GraphPad Prism version 4.00 for Windows,
GraphPad Software, San Diego, CA, USA.
RESULTS
THE INFLUENCE OF POLYMORPHISMS IN PRR GENES ON THE
SUSCEPTIBILITY TO RVVC
As a polymorphism in the gene encoding the CLR DECTIN-
1 (CLEC7A) has previously been shown to be associated with
an increased susceptibility to fungal infections, a ﬁrst set of
comparisons assessed the prevalence of CLEC7A and CARD9
polymorphisms in control individuals and patients with RVVC
(Table 1). No effects of CLEC7A (Tyr238X, rs16910526) and
CARD9 (Ser12Asn, rs4077515) polymorphisms on the susceptibil-
ity to RVVC have been observed. In a second set of experiments,
the prevalence of polymorphisms in the genes coding for TLR1
(Arg80Thr, rs5743611), TLR2 (Pro631His, rs5743704), and TLR4
(Asp299Gly, rs4986790; Thr399Ile, rs4986791) was also assessed.
These analyses revealed that the polymorphisms in the TLR1 and
TLR4 genes did not affect the susceptibility to RVVC. In contrast,
the genotype for the Pro631His polymorphism on the TLR2 gene
was associated with a 2.705-fold increase (P-value 0.046) in sus-
ceptibility to RVVC in the patient cohort. All genetic distributions
are in Hardy–Weinberg equilibrium (Table 1).
BIO-INFORMATIC ANALYSIS TLR2 rs5743704 POLYMORPHISM
Because the TLR2 Pro631His polymorphism was associated with
an increased susceptibility to RVVC, the functional effects of this
genetic variation were studied. In a ﬁrst analysis, an in silico eval-
uation of the effect of the Pro631His polymorphism on the TLR2
protein was performed. We evaluated its effect at the genomic
level, by performing multiple sequence alignment of the homolo-
gous DNA sequences from 35 other species via the Ensembl server.
The cytosine base is conserved at the chromosome 4 nucleotide
position 154625451, being also the ancestral allele, evolutionary
conservation that underlines a high likelihood that this position
in the molecule is functionally important.
To analyze the effects of the SNP rs5743704 on the TLR2 pro-
tein, we analyzed the possible domains identiﬁed via the Prosite
server. The amino acid change for the Pro631His polymorphism
affects an amino acid residue that is located near the TIR domain
(residue 639–784). To visualize the Pro631His polymorphism on
the 3D structure of the TIR domain, we evaluated the homol-
ogy model using the YASARA software. A screenshot of the 3D
homology model is shown in Figure 1. The amino acid change
is situated between the intracellular domain and the TIR domain,
and might introduce a loss in rigidity when substituting proline
by histidine.
Finally, the HOPE server predicted that due to the fact
that the polymorphism introduces an amino acid with different
Table 1 | Genetic association of recurrent vulvovaginal candidiasis (RVVC) with polymorphisms in DECTIN-1, CARD9,TLR1,TLR2, and TLR4
genes.
Polymorphism Group WT HET HOM In HWE
(yes/no)
P -value∗ OR (95% CI)
DECTIN-1 Tyr238Stop Controls (N = 263) 219 (83.3%) 44 (16.7%) 0 (0%) Yes 0.852 0.95 (0.53–1.70)
RVVC (N = 119) 100 (84.0%) 19 (16.0%) 0 (0%) Yes
CARD9Ser12Asn Controls (N = 263) 90 (34.2%) 127 (48.3%) 46 (17.5%) Yes 0.563 1.03 (0.76–1.40)
RVVC (N = 119) 43 (36.1%) 51 (42.9%) 25 (21.0%) Yes
TLR1Arg80Thr Controls (N = 263) 232 (88.2%) 29 (11.0%) 2 (0.8%) Yes 0.46 1.41 (0.81–2.43)
RVVC (N = 119) 100 (84.0%) 17 (14.3%) 2 (1.7%) Yes
TLR2Pro631His Controls (N = 263) 252 (95.8%) 11 (4.2%) 0 (0%) Yes 0.046 2.71 (1.15–5.85)
RVVC (N = 119) 107 (89.9%) 11 (9.2%) 1 (0.9%) Yes
TLR4Asp299Gly Controls (N = 263) 230 (87.5%) 32 (12.2%) 1 (0.5%) Yes 0.791 0.90 (0.47–1.73)
RVVC (N = 119) 105 (88.2%) 14 (11.8%) 0 (%) Yes
TLR4Thr399Ile Controls (N = 263) 230 (87.5%) 32 (12.2%) 1 (0.3%) Yes 0.791 0.90 (0.47–1.73)
RVVC (N = 119) 105 (88.2%) 14 (11.8%) 0 (%) Yes
Data are presented as number of individuals (% major or minor allele), P-value and OR (95% CI).
Bold indicates statistically signiﬁcant association.
*Chi-square (χ2) test. WT, wild-type; HET, heterozygous; HOM, homozygous; HWE, Hardy–Weinberg equilibrium.
www.frontiersin.org September 2014 | Volume 5 | Article 483 | 3
Rosentul et al. PRR polymorphisms in RVVC
characteristics, this would affect the function of the molecule.
The wild-type residue proline is rigid, resulting in a characteristic
backbone conformation that might be required at this position.
Additionally, proline is more hydrophobic than histidine, and
this may also inﬂuence the function of the molecule through loss
of hydrophobic interactions on the surface of the protein. This
hypothesis was also tested through a series of web servers to pre-
dict the pathogenicity of the Pro631His amino acid change. As
shown in Supplementary Table 1, according to the Polyphen-
2, SIFT, PANTHER, and snps3D, the effect of the Pro631His
polymorphism is predicted detrimental for TLR2 function.
THE EFFECT OF THE TLR2 Pro631His POLYMORPHISM ON THE
PRODUCTION OF INFLAMMATORY MEDIATORS
In order to assess the functional consequences of the TLR2
Pro631His polymorphism in further detail, cytokine production
of PBMCs stimulated with heat-killed C. albicans was assessed in
a group of healthy volunteers. The major limitation of this part
of the study was that only two individuals in this group were het-
erozygous for the variant allele, which precludes drawing deﬁnitive
conclusions. However, we observed that whereas the IL-1β, IL-
6, and TNFα production was in the same range comparing the
different genotype groups, both individuals bearing the mutated
allele displayed a strongly diminished release of the T-cell derived
cytokines IFNγ and IL-17 (Figure 2), known to be important for
antifungal host defense (Pandiyan et al., 2011; van de Veerdonk
et al., 2011; Johnson et al., 2012). In contrast, MBL circulating
concentrations in the RVVC patients did not differ depending on
the TLR2 genotype (Figure 3).
DISCUSSION
Vulvovaginal candidiasis is one of the most common infections
in women. Despite known risk factors such as the hormonal
status, diabetes, pregnancy or immunosuppressive therapy (Mil-
som and Forssman, 1985; Sobel, 1985,1993; Kent, 1991; Nawrot
et al., 2000), the majority of the patients are healthy women who
are not exposed to these conditions. In the present study, we
FIGURE 1 | Screenshot of the 3D homology model of theTLR2 protein
using theYASARA software.The side chains of the wild-type and mutant
residues are shown in green and red, respectively.
explored whether genetic variation in genes coding for PRRs
involved in Candida recognition (Jouault et al., 2003) affects
susceptibility to RVVC. We show that a non-synonymous poly-
morphism in TLR2 is associated with increased susceptibility to
RVVC. In silico assessment suggested functional consequences
of the TLR2 polymorphism, and this hypothesis is supported
by the decreased production of T-cell derived cytokines IFNγ
and IL-17 in two individuals bearing the mutation. However, a
deﬁnitive conclusion was not able to be drawn due to the low
number of volunteers with TLR2 SNP identiﬁed in the functional
studies.
Genetic variants in PRRs have been previously reported to
inﬂuence predisposition to RVVC. This has been described in a
family of patients with a complete deﬁciency of DECTIN-1, due
to an early stop codon mutation in the CLEC7A gene coding for
the DECTIN-1 receptor (Ferwerda et al., 2009). Functional con-
sequences of DECTIN-1 deﬁciency were demonstrated to include
impaired induction of both innate and adaptive Th17 immune
responses. Furthermore, several other studies have shown the
involvement of adaptive immunity in RVVC in humans (Babula
et al., 2005; De Luca et al., 2013). In addition to RVVC occurrence
in two of the three patients with DECTIN-1 deﬁciencies, all suf-
fered from onychomycosis. This mutation appears to be relatively
common, up to 15% heterozygosity in populations of European
origin, allowing epidemiological studies in heterozygous patients
(Ferwerda et al., 2009). Moreover, heterozygosity in the CLEC7A
gene is associated with increased mucosal Candida colonization
(Plantinga et al., 2009). Thus, we assessed its impact in the present
study. The loss of one functional allele, however, does not seem to
have a major impact on the susceptibility to RVVC. This implies
that only a complete loss-of-function in the molecule is associated
with a signiﬁcant risk for infection. In addition, it has also recently
been shown that this polymorphism does not affect the predispo-
sition to disseminated Candida infections (Plantinga et al., 2009;
Rosentul et al., 2011).
CARD9 is an adaptor molecule mediating signals induced by
DECTIN-1, but also other CLRs. Its role in antifungal immu-
nity has been demonstrated both in knock-out mouse studies
(Gross et al., 2006), as well as by the increased susceptibility to
severe fungal infections in patients defective in this molecule
due to an early stop codon in position Gln295Stop (Glocker
et al., 2009). However, this mutation is rare and has not been
reported in other individuals. The evaluation of the effects of a
known CARD9 Ser12Asn polymorphism did not yield a signif-
icant association with RVVC susceptibility in the present study.
Similarly, we have previously shown that this polymorphism does
not inﬂuence the susceptibility to candidemia (Rosentul et al.,
2011).
In addition to CLRs, TLRs are the second major family
of PRRs involved in the recognition of fungi in general, and
Candida in particular, TLR2, TLR4, and TLR1 being most impor-
tant in antifungal immunity (Netea and Marodi, 2010). While
TLR1 polymorphisms have been recently shown to inﬂuence
susceptibility to candidemia (Plantinga et al., 2012), no such
effect was apparent in patients with RVVC. Similarly, two TLR4
polymorphisms that have been previously associated with sus-
ceptibility to Gram-negative sepsis and other infections did not
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FIGURE 2 | Functional analysis on the stimulation with heat-killed
Candida albicans of peripheral blood mononuclear cells
(PBMCs) with different TLR2 Pro631His genotypes. Cytokine
production capacity of TNFα, IL-1β, IL-6, IL-10, IL-17, and IFNγ was
compared between the cells obtained from healthy volunteers
bearing the wild-type or the variant allele of the TLR2
polymorphism. D1: Donor 1, D2: Donor 2. Data are presented
as means ± SEM.
FIGURE 3 | Analysis on the mannose-binding lectin (MBL)
concentrations in serum obtained from RVVC patients bearing the
wild-type or the variant allele of theTLR2 polymorphism Pro631His.
Wt, wild-type; He, heterozygous. Data are presented as means ± SEM.
have a signiﬁcant effect on susceptibility to RVVC (Schroder and
Schumann, 2005).
In contrast, the TLR2 Pro631His polymorphism induced an
almost threefold increase in the susceptibility to RVVC. TLR2 is
an important PRR for C. albicans recognition, activating innate
immune responses both alone and in synergy with DECTIN-1
(Ferwerda et al., 2008). The deﬁciency of TLR2 inﬂuences suscep-
tibility to systemic candidiasis in mice (Netea et al., 2004), but no
studies have been performed in vaginal candidiasis models. The in
silico analysis using homology modeling and conservation analysis
suggests detrimental effects of the mutation on the function of the
receptor. This is supported by the study of Etokebe et al. (2010)
that the Pro631His polymorphism has a dominant negative effect
on the TLR2 signaling in HEK-293T cells. Finally, we studied the
functional relevance of this polymorphism in primary cells from
individuals bearing the various alleles. Although we were able to
assess cytokine production in only two individuals with a mutant
TLR2 allele, both of them consistently produced very low amounts
of the T-cell derived cytokines IFNγ and IL-17, mediators that are
crucial for mucosal antifungal defense (Ferwerda et al., 2009; van
de Veerdonk et al., 2011). This observation is supported by the
ﬁnding of Ben-Ali et al. (2011) who demonstrated that the 631His
TLR2 variant leads to reduced NF-κB activation.
In addition to the effects of the TLR2 polymorphism on
cytokine production, we have also assessed its inﬂuence on the
concentrations of MBL. MBL is a circulating receptor for mannose
residues which activates the complement system and opsonizes
Candida (Babula et al., 2005). MBL deﬁciency is associated with
an increased susceptibility to RVVC (Babula et al., 2003; Kaoro
Horie Wojitani et al., 2012). However, no differences in serum
MBL concentrations were found between individuals bearing dif-
ferent TLR2 alleles, showing that the effect of the TLR2 Pro631His
polymorphism on the RVVC susceptibility is independent of the
production of MBL. Ideally, the cytokine analyses should be
extended to assessment in lavage ﬂuids or cells. However, these
materials were not collected from the patients presented in this
manuscript, and future studies should address this aspect.
In conclusion, in this study we provide evidence that poly-
morphisms in PRRs may play an important role in susceptibility
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to RVVC in otherwise healthy women. While CLEC7A, CARD9,
TLR1, and TLR4 polymorphisms had no impact, the TLR2
Pro631His polymorphism was associated with an almost 3-fold
increase in susceptibility toRVVC.These data demonstrate the role
of TLR2 genetic variation in innate immunity genes for RVVC,and
future investigations are warranted in larger cohorts if possible to
replicate and extend the results of the present study.
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